News in other languages: Theraclion

07-23	THERACLION AMORCE SA DYNAMIQUE COMMERCIALE AU PREMIER SEMESTRE 2026
07-15	Theraclion: BILAN DU PREMIER SEMESTRE 2026 DU CONTRAT DE LIQUIDITÉ CONTRACTÉ AVEC LE CRÉDIT INDUSTRIEL ET COMMERCIAL
07-09	Vincent Gardès prend la présidence du conseil d'administration de Theraclion
07-09	THERACLION RENFORCE SA GOUVERNANCE EN NOMMANT VINCENT GARDÈS À LA PRÉSIDENCE DE SON CONSEIL D'ADMINISTRATION
06-19	Bourse : Crédit Agricole veut jouer un rôle en Italie, 2CRSi va communiquer

More news

Managers and Directors: Theraclion

Manager	Title	Age	Since
Martin Deterre CEO	Chief Executive Officer	-	23/05/2023
Julie Veisseire DFI	Director of Finance/CFO	-	-
Alexandra Rocher COO	Chief Operating Officer	-	-

Director	Title	Age	Since
Mehdi El Glaoui BRD	Director/Board Member	-	21/06/2021
Cédric Bellanger BRD	Director/Board Member	-	27/01/2022
Lijuan Deng BRD	Director/Board Member	-	28/06/2023

More insiders

Other Advanced Medical Equipment & Technology

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
THERACLION	-1.66%	+2.24%	+1.02%	-10.00%	51.05M
THERMO FISHER SCIENTIFIC, INC.	+0.96%	+4.42%	+30.16%	+9.52%	220B
DANAHER CORPORATION	+2.25%	+7.38%	+4.39%	-18.23%	144B
INTUITIVE SURGICAL, INC.	+3.85%	+11.34%	-16.32%	+29.36%	134B
BOSTON SCIENTIFIC CORPORATION	+2.33%	+7.98%	-51.08%	-1.18%	71.46B
EDWARDS LIFESCIENCES CORPORATION	+2.57%	+6.92%	+17.46%	+18.03%	51.71B
SIEMENS HEALTHINEERS AG	-0.86%	+6.27%	-15.64%	-18.57%	50.84B
AGILENT TECHNOLOGIES, INC.	+1.88%	+7.48%	+29.75%	+16.52%	41.23B
WATERS CORPORATION	+1.21%	+9.13%	+46.43%	+41.01%	39.95B
GE HEALTHCARE TECHNOLOGIES INC.	+1.63%	+7.23%	+1.31%	-1.33%	32.42B
Average	+1.42%	+3.52%	+4.75%	+6.51%	78.51B
Weighted average by Cap.	+1.89%	+5.45%	+5.93%	+7.10%

See all sector performances

Theraclion specializes in developping, manufacturing and marketing echotherapy equipment associating therapy with focused ultrasound (HIFU) and monitoring by ultrasound. The company provides Echopulse, a device for non-invasive and outpatient treatment of mammary fibroadenoma and thyroid nodules.Net sales break down by activity as follows: - sale of consumables (52.8%); - sale of equipment (28.8%); - provision of after-sales services (18.4%). The vast majority of net sales are earned abroad.

Employees

Sector

Advanced Medical Equipment & Technology

Calendar

10-14 Earnings release - Q2 2026

More about the company

Quotes

Date	Price	Change	Volume
10/08/26	€0.5940	-1.66%	48,934
07/08/26	€0.6040	0.00%	26,774
06/08/26	€0.6040	-0.98%	4,090
05/08/26	€0.6100	-3.33%	16,939
04/08/26	€0.6310	+7.50%	116,349

Real-time Euronext Paris

More quotes

Income Statement and Estimates

More financial data

Annual profits - Rate of surprise

Company calendar

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

Market Cap	43.43M 50.12M 40.61M 37.11M 69.86M 4.78B 71.04M 476M 187M 2.39B 188M 184M 7.98B	P/E 2024	-2.66x	P/E 2025	-6.33x
Enterprise Value	51.28M 59.18M 47.96M 43.82M 82.5M 5.64B 83.88M 562M 220M 2.82B 222M 217M 9.43B	EV / Sales 2024	22.5x	EV / Sales 2025	55.4x
Free-Float	54.78%	Yield 2024 *	-	Yield 2025	-

07-23	Theraclion SA Reports Consolidated Revenue Results for the First Half Ended June 30, 2026	CI
07-09	Theraclion Announces Board Changes	CI
07-09	Theraclion Appoints New Chairman	MT
06-19	Claude Lenoir appointed interim chairman of Theraclion
06-19	Theraclion Chairman Steps Down; Interim Successor Named	MT
06-18	Theraclion Announces Board Changes	CI
06-08	Theraclion Secures AMA CPT Editorial Panel Approval For New Category III CPT Code For Sonovein	CI
06-05	Theraclion deploys first Sonovein system in China
06-05	Theraclion JV Deploys Sonovein System at Chinese Hospital	MT
06-04	Theraclion Announces First Clinical Deployment Of Sonovein In Hainan, China	CI
06-04	Theraclion Deploys Sonovein System At Boao Super Hospital in Hainan Province	CI
06-01	Theraclion Presents Promising Preliminary Results From Sonovein SpeedPulse At First International HIFU Congress	CI
05-11	Bouygues, Euronext, Vallourec... stocks to watch today in Paris

07-23	Theraclion Initiates Its Commercial Momentum in the First Half of 2026	BU
07-15	Theraclion: First Half 2026 Report on the Liquidity Contract With CRÉDIT INDUSTRIEL ET COMMERCIAL	BU
07-09	Theraclion Strengthens Its Governance by Appointing Vincent Gardès as Chairman of Its Board of Directors	BU
06-18	Theraclion Announces the Evolution of Its Board of Directors	BU
06-08	Theraclion Secures Key U.S. Reimbursement Milestone for Sonovein® With AMA CPT Editorial Panel Approval of a New Category III CPT Code	BU

1 day	-1.66%
1 week	+2.24%
Current month	+2.24%
1 month	-11.34%
3 months	+0.68%
6 months	-13.16%
Current year	-1.33%

1 week	0.59	0.64
1 month	0.54	0.68
Current year	0.4	0.93
1 year	0.4	1.25
3 years	0.14	1.25
5 years	0.14	2.22
10 years	0.14	7.46

Theraclion Share Price

Stocks

ALTHE

FR0010120402

Advanced Medical Equipment & Technology

Valuation: Theraclion

Chart: Theraclion

Latest news : Theraclion

Press Releases: Theraclion

News in other languages: Theraclion

Quotes and Performance

Course Extremes

Managers and Directors: Theraclion

Other Advanced Medical Equipment & Technology

Financials

Company Profile

Quotes

Income Statement and Estimates

Annual profits - Rate of surprise

Market Closed - Euronext Paris Other stock markets 16:55:00 10/08/2026 BST			5-day change	1st Jan Change
0.5940 ^EUR	-1.66%		+2.24%	-1.33%

	2024	2025
Net sales	830K 958K 776K 709K 1.34M 91.34M 1.36M 9.1M 3.57M 45.66M 3.6M 3.52M 153M	652K 753K 610K 557K 1.05M 71.73M 1.07M 7.15M 2.8M 35.86M 2.82M 2.76M 120M
Net income	-5.76M -6.64M -5.38M -4.92M -9.26M -633M -9.42M -63.1M -24.74M -317M -24.94M -24.4M -1.06B	-5.69M -6.57M -5.32M -4.86M -9.15M -626M -9.31M -62.37M -24.46M -313M -24.65M -24.12M -1.05B
Net Debt	3.41M 3.94M 3.19M 2.91M 5.49M 375M 5.58M 37.38M 14.66M 188M 14.78M 14.46M 627M	7.85M 9.06M 7.34M 6.71M 12.63M 864M 12.84M 86.06M 33.75M 432M 34.02M 33.28M 1.44B